BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15735012)

  • 1. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
    Raju SC; Hauff SJ; Lemieux AJ; Orosco RK; Gross AM; Nguyen LT; Savariar E; Moss W; Whitney M; Cohen EE; Lippman SM; Tsien RY; Ideker T; Advani SJ; Nguyen QT
    Oral Oncol; 2015 May; 51(5):470-5. PubMed ID: 25735654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.
    Gross AM; Orosco RK; Shen JP; Egloff AM; Carter H; Hofree M; Choueiri M; Coffey CS; Lippman SM; Hayes DN; Cohen EE; Grandis JR; Nguyen QT; Ideker T
    Nat Genet; 2014 Sep; 46(9):939-43. PubMed ID: 25086664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.
    Chihanga T; Vicente-Muñoz S; Ruiz-Torres S; Pal B; Sertorio M; Andreassen PR; Khoury R; Mehta P; Davies SM; Lane AN; Romick-Rosendale LE; Wells SI
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of the Repair of DNA Double Strand Breaks in the Development of Oral Cancer.
    Prime SS; Darski P; Hunter KD; Cirillo N; Parkinson EK
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.
    Scheckenbach K; Wagenmann M; Freund M; Schipper J; Hanenberg H
    Klin Padiatr; 2012 Apr; 224(3):132-8. PubMed ID: 22504776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
    van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
    Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults.
    Schneider M; Chandler K; Tischkowitz M; Meyer S
    Clin Genet; 2015 Jul; 88(1):13-24. PubMed ID: 25307146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma.
    de Roest RH; Stigter van Walsum M; van der Schilden K; Brakenhoff RH
    EJNMMI Res; 2024 Mar; 14(1):22. PubMed ID: 38424294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance gene.
    Gao Y; Guitton-Sert L; Dessapt J; Coulombe Y; Rodrigue A; Milano L; Blondeau A; Larsen NB; Duxin JP; Hussein S; Fradet-Turcotte A; Masson JY
    Nat Commun; 2023 Jan; 14(1):381. PubMed ID: 36693839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma.
    Pai G; Roohollahi K; Rockx D; de Jong Y; Stoepker C; Pennings C; Rooimans M; Vriend L; Piersma S; Jimenez CR; De Menezes RX; Van Beusechem VW; Brakenhoff RH; Te Riele H; Wolthuis RMF; Dorsman JC
    Commun Biol; 2023 Jan; 6(1):37. PubMed ID: 36639418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted protein markers in oral squamous cell carcinoma (OSCC).
    Mumtaz M; Bijnsdorp IV; Böttger F; Piersma SR; Pham TV; Mumtaz S; Brakenhoff RH; Akhtar MW; Jimenez CR
    Clin Proteomics; 2022 Feb; 19(1):4. PubMed ID: 35130834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
    Roohollahi K; de Jong Y; Pai G; Zaini MA; de Lint K; Sie D; Rooimans MA; Rockx D; Hoskins EE; Ameziane N; Wolthuis R; Joenje H; Wells SI; Dorsman J
    Sci Rep; 2022 Jan; 12(1):45. PubMed ID: 34997070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.
    Gruijs M; Ganzevles SH; Stigter-van Walsum M; van der Mast R; van Ostaijen-Ten Dam MM; Tuk CW; Schilham MW; Leemans CR; Brakenhoff RH; van Egmond M; van de Ven R; Bakema JE
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications.
    van Harten AM; Brakenhoff RH
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
    Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Deregulated Pathways, Key Regulators, and Novel miRNA-mRNA Interactions in HPV-Mediated Transformation.
    Babion I; Miok V; Jaspers A; Huseinovic A; Steenbergen RDM; van Wieringen WN; Wilting SM
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32188026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
    van Harten AM; de Boer DV; Martens-de Kemp SR; Buijze M; Ganzevles SH; Hunter KD; Leemans CR; van Beusechem VW; Wolthuis RMF; de Menezes RX; Brakenhoff RH
    Sci Rep; 2020 Feb; 10(1):2330. PubMed ID: 32047167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-9-5p Exerts a Dual Role in Cervical Cancer and Targets Transcription Factor TWIST1.
    Babion I; Jaspers A; van Splunter AP; van der Hoorn IAE; Wilting SM; Steenbergen RDM
    Cells; 2019 Dec; 9(1):. PubMed ID: 31888045
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.